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 Abstract 
This study examined HIV patients’ attitude towards the practice of organ transplant between 
HIV patients using a cross-sectional survey design. In total, 206 patients participated with a 
mean age of 42 (+/- 8.8) years. The majority (70%) were black African and female (54%), 
and 83% described themselves as heterosexual. Most participants (n=171, 83%) were on 
treatment and159 (93%) had viral load less than 40 copies/ ml. Mean duration of illness and 
mean duration of treatment were 77 (+/-42.7) and 68 (+/-41) months respectively. Of all 
participants, 128 (62%) reported that they would consider donating either any organ or a 
specific organ/s to an HIV patient, 33 (16%) would not consider it and 45 (22%) were unsure 
about donating their organs. Furthermore, 113 (55%) participants would consider receiving 
an organ from an HIV patient, 37 (18%) would not consider it, and 56 (27%) were unsure. 
Ninety eight participants (42%) reported that they would consider both donating and 
receiving an organ. Multinomial logistic regression analysis found that significantly more 
Black African than Caucasian participants were unsure about organ donation (p=0.011, 
OR=3.887).  Participants with longer duration of infection were significantly less likely to 
consider receiving an organ from an HIV patient (p=0.036, OR=1.297). Overall the study 
findings indicated that the majority of participants were in favour of organ transplant between 
HIV patients. Use of HIV infected donors could potentially reduce current organ waiting list 
among HIV patients. 
 
 
 
 
Background 
In the era of Highly Active Antiretroviral Therapy (HAART), the spectrum of HIV disease has 
changed dramatically [1, 2]. Non-AIDS defining illnesses are becoming more common 
causes of HIV related mortalities and morbidities compared to AIDS defining illnesses [2, 3]. 
Key examples of non-AIDS defining illnesses include End-stage Kidney Disease (ESKD) and 
End-stage Liver Disease (ESLD), both of which have multi-factorial origins [1, 4-7]. Kidney 
transplant and liver transplant could be an attractive proposition for patients who present 
with end-stage disease [8-10]. Recent results from a series of cases in the UK in which HIV 
patients have received organ transplants from HIV negative donors are encouraging [11]. 
Transplants between HIV positive patients however is not a current practice, significantly 
reducing the pool of available organs. The American federal law has recently lifted the ban 
on organ donation between HIV infected individuals, a move that offers hope to thousands of 
HIV patients on transplant waiting lists [12]. This procedure is however yet to be performed 
in the USA. Instead the only country to have allowed this to happen is South Africa. Here, 
outcomes to date have been largely positive for the organ recipients [13].The changing 
circumstances in the USA and South Africa, and tentative evidence of successful outcomes 
for HIV patients, may have implications for UK practice. In anticipation of a possible change 
in UK law in the future, the aim of this study was to explore the attitude of UK HIV patients 
toward organ transplant between HIV infected patients. 
 
Methodology 
This study had a cross sectional survey design. Over a period of 3 months, all HIV patients 
attending for a routine follow-up at a HIV outpatient clinic within a large city centre 
Genitourinary Medicine (GUM) department, were invited to participate. A sample size of 150 
to 200 participants was aimed for. This was judged to be sufficiently large to provide 
reasonably robust estimates of effect sizes. Participants completed a questionnaire written in 
simple English, with largely fixed response questions (appendix 1). The questions were 
initially developed by two GUM doctors and then piloted with 15 patients to identify their 
suitability and ease of comprehension. Some minor changes to the wording were made as a 
result. Informed consent and completion of questionnaires took place in a private room.  
Participant’s Demographic data including age, gender, ethnicity, sexual orientation, duration 
of HIV infection and both clinical and treatment history were collected. Ethical approval was 
obtained from a regional ethical committee. Patients were eligible to participate if they had a 
documented positive HIV antibody test according to the standard of HIV diagnosis, provided 
informed consent, and were age 18 years or over. Participants were also required to have a 
reasonable grasp of the English language or were alternatively able to communicate 
adequately with the help of an interpreter. We excluded patients with primary HIV infection, 
who didn’t consent, had poor knowledge of English and declined to use an interpreter, or 
were known to suffer from a mental health problem.  
Responses to the questionnaires and information from the case notes were entered into 
SPSS (version 15.0) for analysis. Frequency analysis and multinomial logistic regression 
were performed. 
 
Results 
Sample description: 
308 patients attended the clinic during the study and 206 chose to participate giving a 
response rate of 67%. The mean age of the participants was 42 (+/-8.8) years. Most 
reported that they were black African (n= 145, 70%, CI=+/- 6.26) and heterosexual (n= 171, 
83%, CI=+/- 5.13). There were more females (n=111, 54%, CI=+/-6.81) than males (n=95, 
46%, CI=+/-6.81). Mean Cd-4 cell count was 486 (+/-231) cells per dl and most participants 
(90%, CI=+/-4.1) were on treatment. Viral load was undetectable in 93% of the participants. 
The mean duration of illness was 77 (+/-42 .7) months and the mean length of time on 
HAART was 68 (+/-41) months (table 1) Seventy one (34%, CI=+/-6.47) participants had a 
history of opportunistic infection. One hundred and four (50%, CI=+/-6.83) participants had 
co- morbidities (table 2) including diabetes mellitus, hypertension, impaired renal function 
(defined as e-GFR below 60 ml/min/1.73m2 at the time of the study), ischemic heart 
disease, peripheral vascular disease, deranged liver function, auto-immune hepatitis, 
anaemia, and osteoarthritis. Five participants (2%, CI=+/-1.91) had a history of cancer. 
Twelve (6%, CI=+/-3.24) participants had Hepatitis B and/ or C infection. Alcohol related 
problems were documented in 7 (3%, CI=+/-2.33). 
Attitude towards donating organs to HIV infected patients 
Participants were asked whether they would consider donating an organ to another HIV 
infected patient. One hundred and twenty eight participants (62%, CI=+/-6.63) indicated that 
they would donate an organ. Another 33 (16%, CI=+/-5.01) indicated they would not and 45 
(22%, CI=+/-5.66) were not sure (figure1). Those who would consider donating an organ to 
another HIV infected patient (n=128), were asked to indicate whether this was specifically 
their liver, kidney, heart or other organ. Eighty two (70%, CI=+/-7.94) participants indicated 
they would consider donating their liver, 96 (81%, CI=+/-6.80) their kidney, 75 (63%, CI=+/-
8.36) their heart, and 17 (14%, CI=+/-6.01) another type of organ. Sixty eight (58%, CI=+/-
8.55) participants responded that they would consider donating all three specified organs. 
Multinomial logistic regression was performed to examine whether there was an independent 
effect of any of the demographic and HIV characteristics on attitude towards organ donation. 
Findings indicated that an individuals’ attitude towards organ donation to HIV infected 
patients was not associated with their age, gender, duration of infection or duration of 
HAART. However there was a significant effect of ethnicity. Black African participants were 
more likely than Caucasian participants to indicate that they were not sure if they would 
consider organ donation (compared to those who would consider donation) (p=0.011, 
OR=3.887, CI=1.36-11.08) (table 3). 
Attitude towards receiving an organ from HIV infected patients 
Participants were asked whether they would consider receiving an organ from a HIV infected 
patient. One hundred and thirteen (55%, CI=+/-6.79) participants indicated that they would, 
37 (18%, CI=+/-5.25) participants reported that they would not, and 56 (27%, CI=+/-6.06) 
participants were not sure (Figure 1). 
Of the 113 participants who would consider receiving an organ, 103 participants indicated 
their preferred type of donor. Fourteen (14%, CI=+/-6.70) participants reported that they 
would prefer a live donor, 6 (6%, CI=+/-4.59) reported that they would prefer a deceased 
donor, and 83 (80%, CI=+/-7.82) participants reported ‘either’. Participants who reported that 
they would not consider receiving an organ from an HIV infected individual were asked what 
their main concerns were (participants could endorse more than one response). The 
proportion who endorsed each response was as follows: confidentiality 26% (CI=+/-14.13), 
infection 23% (CI=+/-13.56), quality of organ 23% (CI=+/-13.56), and ‘other’ 33% (CI=+/-
15.15). Multinomial logistic regression was performed to examine whether there was an 
independent effect of demographic and HIV characteristics on attitude towards receiving an 
organ. There were no variations in response for the following factors: age, gender, ethnicity, 
or sexuality. Duration of infection however did have an effect and there was a borderline 
effect of duration of HAART. Specifically  participants with a higher number of years of 
infection were more likely to indicate that they would not consider receiving an organ 
compared to those with a lower number of years of infection (p=0.036, OR=1.297, CI=1.02-
1.61). This suggests that as the length of infection increases, HIV patients become less 
willing to consider accepting an organ transplant from another HIV patient. Participants with 
a higher number of years on HAART were more likely to indicate that they would consider 
receiving an organ compared to those with a lower number of years of HAART ( borderline 
significance, p=0.052, OR=0.804, 0.65-1.00). (Borderline significance) (Table 4). 
 
Whether participants’ motivation to accept an organ donation is to stay alive/ improve 
quality of life (QOL) 
Participants were asked whether they would accept an organ to stay alive and/or improve 
their quality of life (Reponses were yes, no or other). Out of the 206 participants, one 
hundred and thirty five participants (66%, CI=+/-6.47) indicated that they would accept an 
organ transplant from an HIV infected patient to stay alive and/or improve their quality of live 
(QOL). Multinomial logistic regression was performed to examine the association between 
demographic and HIV characteristics, and responses to the above question. An individual’s 
age, gender, ethnicity, sexuality, duration of infection or duration of HAART was not 
associated with whether they would accept an organ to stay alive and/or improve their QOL. 
 
Discussion  
There is a strong case for organ transplant between HIV patients to prevent unnecessary 
death and improve quality of life. This study aimed to examine the attitude of HIV patients 
towards organ transplant between patients and as far as the authors are aware, is the first 
study of its kind. Out of 206 participants, 62% indicated they would consider donating an 
organ to another HIV patient. Fifty-five percent of participants indicated that they would 
consider receiving organ from HIV infected patient. Of those who would not consider 
receiving a donated organ, approximately a quarter indicated that they were concerned 
about infection, quality of organ, and confidentiality.  
The Euro SIDA study has shown that the death rates from HIV/ AIDS have fallen eight-fold 
between 1994 and 2001 [14]. Studies have shown that non-AIDs related disease including 
drug related toxicities is becoming more common in HIV patients [3]. HIV patients may have 
relatively higher risk of organ failure. HIV patients with end-stage organ disease are likely to 
derive benefit from accepting organs from HIV infected donors. Researchers at the Johns 
Hopkins University School of Medicine estimate that there are approximately 500-600 
potential deceased HIV infected kidney and liver donors per year in the United States [4]. 
Transplants between HIV positive patients could therefore potentially reduce or even 
eliminate the current waiting list for organs among HIV-positive people needing transplants 
this may also shorten waiting times for non-HIV infected patients. Muller and colleagues 
have pioneered positive-to-positive kidney transplants since 2008. They have demonstrated 
that transplanting HIV-infected patients with ESKD with kidneys from HIV-positive donors 
represents a significant advance, benefiting patients with ESKD due to HIV associated 
nephropathy and could be cost effective [13].  
One potential concern relating to organ transplants between HIV positive patients is the 
possibility of super- infection with a different HIV clade or a recombinant virus carried by a 
donor organ. In theory, this could accelerate HIV disease progression in the patient, 
particularly if that strain is resistant to antiretroviral drugs. However, some studies have 
suggested that in patients with well-established HIV infection on HAART, there may be a 
smaller number of host cells that are susceptible to the new HIV strain, hence, low risk of 
super/ dual infection [15]. However, the HIV status of would-be donors should not be 
considered as disadvantage for HIV patients who are living with end organ failure. Doing so 
significantly restricts the pool of potential organ donors to the relatively small HIV positive 
cohort. 
Further trials are needed to investigate positive-to-positive transplants which will yield 
valuable clinical insights into the functioning of HIV and the human immune system [4]. In 
the UK, the imbalance between donor supply and organ need is growing. In conjunction with 
high quality trials to examine clinical risk [4], there is a need for social science research to 
examine attitudes towards organ donation between HIV patients. This is needed to ascertain 
the level of support for a future HIV organ donation programme, specifically whether patients 
are likely to register as donors, be willing to accept an organ donation, and also whether 
receipt from a live or deceased donor is more acceptable. It is also needed in order to 
identify whether there are any particular groups who hold less favourable opinions and why. 
Our survey has shown that HIV patients are largely in support of both donating and receiving 
organs, and that the majority of patients in favour of this are happy to receive an organ from 
either a live or a deceased donor. A significant proportion of participants however indicated 
that they would not want to do this or were unsure. Concerns of participants who would not 
consider receiving an organ include confidentiality, infection and quality of organ. Further 
research is required to explore these concerns in more detail and to understand their basis, 
both for those who are against receiving an organ or unsure. This is particularly important in 
order to develop future patient education about organ donation between HIV patients. This 
study identified some potentially important associations between organ donation attitudes 
and demographic and HIV characteristics. Firstly, attitudes towards organ donation were 
associated with ethnicity. Black African participants were more likely than Caucasian 
participants to indicate that they would not consider donation. This may be due to cultural or 
religious beliefs and further research is required to explore this. Also of interest are the 
findings that participants with higher number of years of infection are less likely to consider 
receiving an organ, but those with higher years of HAART are more likely to consider this. 
Reasons for these apparent inconsistent findings are unknown. Caution should be taken in 
drawing strong conclusions given that the relationship between years of HAART and receipt 
of organ was of borderline significance. Future survey research with a larger sample size is 
required to interrogate this. Qualitative research to further explore these beliefs would also 
be beneficial. 
Limitations 
Limitations of this study should be considered when interpreting the results. These include 
the small number of participants, drawn from a single centre, and mostly of black African 
ethnicity. These factors reduce the external validity of the results. Furthermore the survey 
design meant that there were limits to the conclusions which could be made. As discussed 
above, further research is required, specifically in the first instance a qualitative study, to fully 
explore beliefs underlying attitudes towards organ donation between HIV patients. Ideally 
this would be followed by a further cross-sectional study using a larger, more representative 
sample and more refined questions capable of measuring the strength of these beliefs and 
their association with direct measures of attitude. This would enable us to better understand 
which beliefs are drivers of positive and negative attitudes towards organ donation, and to 
identify any misperceptions which could be addressed through patient education. 
Conclusion 
This study indicates that the attitude of HIV patients towards the practice of organ transplant 
between HIV patients is broadly favourable. Patients with HIV infection should have every 
opportunity to express their views and needs. It is suggested that an organ donation registry 
for patients with HIV infection is instituted and further studies conducted at a national level 
as outlined above. Furthermore, transplantation networks and disciplinary teams will be 
needed to develop ethical and clinical standards to guide medical research on positive-to-
positive transplants. 
 
Category N (%) 
Mean age (+/-SD) 42 (8.8) 
Female Gender (%) 122 (59)  
Black Africans (%) 145 (70) 
Heterosexual (%) 171 (83) 
Mean CD-4 count (+/-SD) 486 (231) 
On HAART (%) 185 (90) 
Mean duration of illness (+/-SD) months 77 (42.7) 
Mean duration of ARV (+/-SD) months 68 (41) 
Co- morbidities (%) 104 (50%) 
Alcohol use (%) 7 (3) 
 
Table 1: Participants baseline results (n=206)   
  
 
 
 
 
 
 
 
 
 
 
 
  
            
 
 
 
 
 
 
 
 
 
 
 
 
Table 2: List of co- morbidities (n=104) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                       Co- morbidity type 
 
N (%) 
Cardiovascular diseases & Hypertension 
 
  22 (11) 
Renal problems 
 
  7 (3) 
Respiratory illnesses 
 
  12 (6) 
Gastro intestinal / liver/ pancreatic illnesses 
 
  4 (2) 
Peripheral vascular disease 
 
  8 (4) 
Diabetes Mellitus 
 
  5 (2) 
Auto immune skin illnesses 
 
  3 (1) 
Gynaecological illnesses 
 
  5 (2) 
Mental illnesses 
 
 10 (5) 
Hepatitis B and or C infection 
 
 12 (6) 
Previous CA 
 
  5 (2) 
Musculoskeletal illnesses 
 
  4 (2) 
Alcohol related illnesses 
 
  7 (3) 
Total 
 
 104 (50) 
  
 
 
 
  Figure 1- Consideration for donating or receiving organ 
 
 
 
 
Table 3: Multinomial logistic regression model to predict attitude toward organ 
donation by demographic variables. 
 
 Not sure would consider organ 
donation 
 Would not consider organ donation 
    OR     95%  CI   P value     OR      95 % CI         P value 
Age  0.98    0.93- 1.04    0.48   1.00    0.94-1.06          0.96 
Gender 1.51    0.64- 3.54     0.34   0.48    1.31 -1.53          0.20 
Ethnicity 3.89   1.36- 11.08     0.01   1.51    0.64- 3.56          0.35 
Duration of 
infection 
1.02   0.82- 1.26     0.90   0.95    0.73- 2.24          0.70 
Duration of 
ARV 
0.95   0.76- 1.18     0.61      1.00    0.77- 1.30          0.99 
  
 
Table 4: Multinomial logistic regression model to predict attitude toward receiving 
organ by demographic variables. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Not sure would consider 
receiving organ 
  Would not consider receiving organ 
    OR     95%  CI   P value     OR      95 % CI         P value 
Age         0.99   0.95- 1.04       0.65  1.03 0.98- 1.10         0.27 
Gender        1.55   0.67- 3.62       0.31   1.05 0.35- 3.15          0.93 
Ethnicity        2.15   0.69- 6.68       0.18  1.37 0.46- 4.08          1.37 
Duration of 
infection 
       0.96   0.78- 1.18       0.67  1.28 1.02- 1.61          0.04 
Duration of 
ARV 
       1.02   0.83- 1.26       0.86   0.80 0.65-1.00          0.05 
Sexuality        2.43   0.23- 25.40       0.46   0.63 0.05- 8.16          0.73 
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